Curcumin improves insulin resistance in skeletal muscle of rats

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 7, 2011, Pages 526-533

  Na, L X ^a   Zhang, Y L ^a   Li, Y ^a   Liu, L Y ^a   Li, R ^a   Kong, T ^a   Sun, C H ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

AMPK; Curcumin; Insulin resistance; Skeletal muscle

Indexed keywords

AMP ACTIVATED PROTEIN KINASE KINASE; AMP-ACTIVATED PROTEIN KINASE KINASE; ANTIDIABETIC AGENT; CURCUMIN; DEOXYGLUCOSE; PALMITIC ACID; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; STK11 PROTEIN, RAT;

ANIMAL; ARTICLE; BLOOD; CELL LINE; CHEMISTRY; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; FAT INTAKE; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; METABOLISM; RANDOMIZATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CURCUMIN; DEOXYGLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; DIETARY SUPPLEMENTS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; PALMITIC ACID; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RANDOM ALLOCATION; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

RATTUS;

EID: 79959508832     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.11.009     Document Type: Article

References (35)

1. DeFronzo R.A., Gunnarsson R., Bjorkman O., Olsson M., Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 1985, 76:149-155.
2. Ritchie S.A., Connell J.M. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007, 17:319-326.
3. Villegas R., Shu X.O., Yang G., Matthews C.E., Li H., Cai H., et al. Energy balance and type 2 diabetes: a report from the Shanghai Women's Health Study. Nutr Metab Cardiovasc Dis 2009, 19:190-197.
4. Phillips D.I., Caddy S., Ilic V., Fielding B.A., Frayn K.N., Borthwick A.C., et al. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 1996, 45:947-950.
5. Pan D.A., Lillioja S., Kriketos A.D., Milner M.R., Baur L.A., Bogardus C., et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997, 46:983-988.
6. Schalch D.S., Kipnis D.M. Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids. J Clin Invest 1965, 44:2010-2020.
7. Lionetti L., Mollica M.P., Lombardi A., Cavaliere G., Gifuni G., Barletta A. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Nutr Metab Cardiovasc Dis 2009, 19:146-152.
8. Goodpaster B.H., Kelley D.E. Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?. Curr Diab Rep 2002, 2:216-222.
9. Krssak M., Falk Petersen K., Dresner A., DiPietro L., Vogel S.M., Rothman D.L., et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999, 42:113-116.
10. Patel J., Anderson R.J., Rappaport E.B. Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study. Diabetes Obes Metab 1999, 1:165-172.
11. Comaschi M., Corsi A., Di Pietro C., Bellatreccia A., Mariz S. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia. Nutr Metab Cardiovasc Dis 2008, 18:373-379.
12. Ferrannini E., Natali A., Bell P., Cavallo-Perin P., Lalic N., Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 1997, 100:1166-1173.
13. Rosenfalck A.M., Hendel H., Rasmussen M.H., Almdal T., Anderson T., Hilsted J., et al. Minor long-term changes in weight have beneficial effects on insulin sensitivity and beta-cell function in obese subjects. Diabetes Obes Metab 2002, 4:19-28.
14. Kuroda M., Mimaki Y., Nishiyama T., Mae T., Kishida H., Tsukagawa M., et al. Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol Pharm Bull 2005, 28:937-939.
15. Seo K.I., Choi M.S., Jung U.J., Kim H.J., Yeo J., Jeon S.M., et al. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol Nutr Food Res 2008, 52:995-1004.
16. Jang E.M., Choi M.S., Jung U.J., Kim M.J., Kim H.J., Jeon S.M., et al. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metabolism 2008, 57:1576-1583.
17. Yu Y., Hu S.K., Yan H. The study of insulin resistance and leptin resistance on the model of simplicity obesity rats by curcumin. Zhonghua Yu Fang Yi Xue Za Zhi 2008, 42:818-822.
18. Yi X., Maeda N. Alpha-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet. Diabetes 2006, 55:2238-2244.
19. Abumrad N., Harmon C., Ibrahimi A. Membrane transport of long-chain fatty acids: evidence for a facilitated process. J Lipid Res 1998, 39:2309-2318.
20. McGarry J.D., Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 1997, 244:1-14.
21. Holness M.J., Sugden M.C. Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem Soc Trans 2003, 31:1143-1151.
22. Sugden M.C., Holness M.J. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol Endocrinol Metab 2003, 284:E855-E862.
23. Corcoran M.P., Lamon-Fava S., Fielding R.A. Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise. Am J Clin Nutr 2007, 85:662-677.
24. Ruderman N.B., Saha A.K., Vavvas D., Witters L.A. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 1999, 276:E1-E18.
25. Harwood H.J., Petras S.F., Shelly L.D., Zaccaro L.M., Perry D.A., Makowski M.R., et al. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J Biol Chem 2003, 278:37099-37111.
26. Ejaz A., Wu D., Kwan P., Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 2009, 139:919-925.
27. Asai A., Miyazawa T. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 2001, 131:2932-2935.
28. Hardie D.G. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 2008, 32(Suppl. 4):S7-S12.
29. Shulman G.I., Rothman D.L., Jue T., Stein P., DeFronzo R.A., Shulman R.G. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990, 322:223-228.
30. Hardie D.G. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 2004, 117:5479-5487.
31. Weisberg S.P., Leibel R., Tortoriello D.V. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 2008, 149:3549-3558.
32. Wang S.L., Li Y., Wen Y., Chen Y.F., Na L.X., Li S.T., et al. Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. Biomed Environ Sci 2009, 22:32-39.
33. Best L., Elliott A.C., Brown P.D. Curcumin induces electrical activity in rat pancreatic beta-cells by activating the volume-regulated anion channel. Biochem Pharmacol 2007, 73:1768-1775.
34. Meghana K., Sanjeev G., Ramesh B. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. Eur J Pharmacol 2007, 577:183-191.
35. Pari L., Murugan P. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren Fail 2007, 29:881-889.